(MedPage Today) — Two biomarker tests — one for blood and the other for stool — are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from noninvasive tests.
“A…
Source link : https://www.medpagetoday.com/spotlight/ddw-ibd/116191
Author :
Publish date : 2025-06-23 14:47:00
Copyright for syndicated content belongs to the linked Source.
